Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease

By Luthi-Carter Ruth   Strand Andrew   Peters Nikki L.   Solano Steven M.   Hollingsworth Zane R.   Menon Anil S.   Frey Ariel S.   Spektor Boris S.   Penney Ellen B.   Schilling Gabriele   Ross Christopher A.   Borchelt David R.   Tapscott Stephen J.   Young Anne B.   Cha Jang-Ho J.   Olson James M.  

Human Molecular Genetics, Vol. 9, Iss. 9, 2000-05 ,pp. : 1259-1271

Oxford University Press

Access to resources Recommend Favorite

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

By Borchelt D.R.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1927-1937

Oxford University Press

Access to resources Recommend Favorite

Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington’s disease?

By Kennedy Laura   Shelbourne PeggyF.  

Human Molecular Genetics, Vol. 9, Iss. 17, 2000-10 ,pp. : 2539-2544

Oxford University Press

Access to resources Recommend Favorite

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease

By Rose Claudia   Menzies Fiona M.   Renna Maurizio   Acevedo-Arozena Abraham   Corrochano Silvia   Sadiq Oana   Brown Steve D.   Rubinsztein David C.  

Human Molecular Genetics, Vol. 19, Iss. 11, 2010-06 ,pp. : 2144-2153

Oxford University Press

Access to resources Recommend Favorite

Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington’s disease

By Priller J.  

Human Molecular Genetics, Vol. 10, Iss. 12, 2001-06 ,pp. : 1307-1315

Oxford University Press

Access to resources Recommend Favorite